It is a pharma private limited company based in New Delhi, Delhi, India, established in 2006.
2006 | New Delhi, Delhi, India | ActiveRayan Laboratories Private Limited, a active private limited company, was established on 20 September 2006 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24234DL2006PTC211385. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.30 M and a paid-up capital of ₹23.00 K .
It upholds a active non-compliant status. Its leadership includes Talib Hussain (Additional Director), Arun Kumar (Additional Director). Past directors included Ruhi Anjum, Prem Kumar Malik, Pedamallu Venkateswara Rao. It holds ₹1.95 Cr open charges and ₹3.18 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 30/31, Basement Old Rajender Nagar, New Delhi, Delhi, 110060.
U24234DL2006PTC211385
211385
20 September 2006
₹2.30 M
₹23.00 K
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rayan Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Talib Hussain | Additional Director | 01 Feb 2024 | Current |
| Arun Kumar | Additional Director | 01 Feb 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 05 Feb 2024 | Past |
| Pramod Abcsdd | Additional Director | 01 Dec 2014 | Past |
| Pramod Abcsdd | Director | 29 Dec 2009 | Past |
| Pramod Abcsdd | Additional Director | 10 Feb 2011 | Past |
| Pramod Abcsdd | Director | 01 Dec 2014 | Past |
| Pramod Abcsdd | Director | 05 Feb 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rayan Laboratories Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 21.32% decrease. The company also saw a substantial fall in profitability, with a 487.98% decrease in profit. The company's net worth dipped by a decrease of 9.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2015, Rayan Laboratories had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹19,500,000.00
₹31,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Oct 2024 | Others | ₹9.50 M | Open |
| 15 Oct 2024 | Others | ₹1.00 Cr | Open |
| 31 Mar 2010 | Canara Bank | ₹3.18 Cr | Satisfied |
Explore comprehensive loan charge details -
Rayan Laboratories has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rayan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rayan Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 9.50 M with Charge ID 101000479 was registered on 15 Oct 2024. was documented.
A charge with Others amounted to Rs. 10.00 M with Charge ID 101000392 was registered on 15 Oct 2024. was recorded as a recent event.
The activity Rayan Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge registered on 31 Mar 2010 via Charge ID 10213027 with Canara Bank was fully satisfied on 17 Sep 2024. was recorded as a recent event.
Rayan Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Talib Hussain was appointed as a Additional Director was appointed as a Additional Director on 01 Feb 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
The CIN of Rayan Laboratories Private Limited is U24234DL2006PTC211385.
Rayan Laboratories Private Limited is headquartered at 30/31, Basement Old Rajender Nagar, New Delhi, Delhi, 110060.
Rayan Laboratories Private Limited was incorporated on 20 September 2006.
The current directors of Rayan Laboratories Private Limited are
The primary industry of Rayan Laboratories Private Limited is Pharma.
Rayan Laboratories Private Limited is unlisted.
The authorized capital of Rayan Laboratories Private Limited is ₹2.30 M, and the paid-up capital is ₹23.00 K .
The compliance status of Rayan Laboratories Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX